Baker McKenzie advises Stada on Locobase deal
Baker McKenzie has advised pharmaceutical group Stada Arzneimittel on its acquisition of certain rights to the Locobase dermatology brand from Karo Healthcare, covering commercial rights to the Locobase skincare range in Denmark, Finland, Iceland, Norway and Sweden.
The transaction gives STADA control over a broad portfolio of skincare products targeting consumers with dry, sensitive or barrier-impaired skin, including products used in the care and management of conditions such as eczema and psoriasis.
About the parties
Stada is an international pharmaceutical group operating across three business pillars: consumer healthcare products, generics and specialty pharma. Karo Healthcare is the seller of the Locobase® brand rights in the Nordic region.
Locobase holds a significant position in the dry skin market across the Nordic countries.
Legal teams
Baker McKenzie’s core advisory team was led by Katja Persson, Daniel Högström and Joan Sardar, with supporting lawyers Seher Budak, William Höglund, Annika López Kasteskog, Peder Oxhammar and Emelie Ageby Svensson (all Stockholm), alongside Frankfurt-based Christian Atzler (pictured left) and Frank Pflueger (pictured right).
The firm worked closely with Stada’s in-house legal team, represented by Marcus Heppner (director legal affairs) and Anna-Maria Krekeler (associate director legal).
